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Abstract
Among the various hematopoı¨etic cells, platelets are critical for maintaining the integrity of the vascular system. They must be rapidly
activated by sequential and coordinated mechanisms in order to efficiently prevent haemorrhage upon vascular injury. Several signal
transduction pathways lead to platelet activation in vitro and in vivo, among them, several are initiated via receptors or co-receptors
containing immuno-receptor tyrosine-based activation motifs (ITAM) which trigger downstream signalling like the immune receptors in
lymphocytes. However, in contrast to immune cells for which the role of lipid rafts in signalling has largely been described, the involvement
of laterally segregated membrane microdomains in platelet activation has been investigated only recently. The results obtained until now
strongly suggest that early steps of platelet activation via the collagen receptor GpVI or via FcgRIIa occur preferentially in these
microdomains where specific proteins efficiently organize key downstream signalling pathways. In addition, lipid rafts also contribute to
platelet activation via heterotrimeric G-protein-coupled receptors. They are sites where the phosphoinositide (PI) metabolism is highly active,
leading to a local generation of lipid second messengers such as phosphatidylinositol 3,4,5-trisphosphate. Here, evidence is accumulating that
cholesterol-enriched membrane microdomains are part of a general process that contributes to the efficiency and the coordination of platelet
activation mechanisms. Here we will discuss the biochemical and functional characterizations of human platelet rafts and their potential
impact in platelet physiopathology.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Platelets play an essential role in haemostasis and pro-
vide an attractive model to studying agonist-mediated signal
transduction mechanisms. Various natural agonists can acti-
vate these enucleated cells, and most of their cognate
receptors are well characterized [1]. The platelet plasma
membrane is the site of interactions between extracellular
stimuli and highly organized intracellular biochemical
events supporting platelet activation. The plasticity (fluidity,
phase transition, lipid microdomains) of the plasma mem-
brane is essential for the efficiency of signal transduction
mechanisms and for physiological platelet responses such as
shape change, spreading, secretion, aggregation and clot
retraction. The platelet plasma membrane, like the plasma
membrane of other mammalian cells, contains a huge
number of lipid molecular species that do not simply act
to maintain the structural integrity of the cell. It is now
becoming clear that individual lipids are also implicated on
their own in the regulation of key cellular functions [2]. The
ratio between the various lipid species, which differs from
one cell to another and can be modified by specific diet,
pathological situations or cell stimulation, is an important
factor for the formation of lateral domains and for mem-
brane plasticity.
In vitro, platelets can be activated by physiological
agonists acting through G-protein-coupled receptors such
as thrombin, thromboxane A2 or adenosine diphosphate
(ADP) receptors [1]. They also have several key receptors
that recruit and activate tyrosine kinase-dependent path-
ways. This is, for instance, the case for GpVI, a collagen
receptor [3], or FcgRIIa, the low-affinity platelet surface
receptor for immune complexes [4]. Those two receptors
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initiate a signalling cascade that shares several features with
the pathways activated by immune receptors in lymphocytes
[3–5]. The clustering of these receptors in the plasma
membrane is an essential initial event allowing the recruit-
ment and the spatio-temporal activation of downstream
signalling proteins. In immune cells, a number of genetic
and biochemical studies support a functional role for lipid
rafts in the onset of immune-receptors mediated signalling
[6–8]. These membrane microdomains play a critical role
for the efficient recruitment and assembly of newly formed
multiprotein complexes at the cytoplasmic side of the
plasma membrane. Despite the limitations of technologies
available to investigate the functions of lipid rafts, recent
biochemical and microscopy approaches strongly suggest
that they play an important role in platelet activation
process. In this paper, we will review the evidences of the
existence of rafts in platelets and focus on their potential
involvement in different types of agonist-mediated activa-
tion. The impact of the membrane cholesterol content on
platelet activation mechanisms and its physiopathological
implications will be discussed.
2. Characterization of platelet lipid rafts
Separate functional domains with different lipid compo-
sitions appear to coexist in biological membranes [8–12].
The liquid-ordered microdomains called lipid rafts are
sphingolipid and cholesterol-based structures consisting of
very small domains (20–50 nm) of tightly packed lipids
displaying lateral mobility [9–11]. Lipid raft formation
should therefore be facilitated in membranes rich in choles-
terol and sphingolipids since the high acyl chain melting
temperature of sphingomyelin promotes the formation of
liquid ordered domains in the presence of cholesterol [9,10].
Interestingly, there is a relatively high amount of sphingo-
myelin in human platelet plasma membrane [13], suggesting
a lipid composition in favour of raft formation in these cells.
In 1996, Dorahy et al. [14] isolated low density, 1% Triton
X-100 resistant glycosphingolipid and cholesterol-enriched
membrane microdomains from human platelets at 4 jC.
Until now, most of the human platelet raft isolation proce-
dures used were based on the insolubility of these lipid
microdomains in Triton X-100 at 4 jC and their ability to
float in sucrose density gradient after ultracentrifugation
[15,16]. However, several authors [16,17] have modified the
Triton X-100 concentration used according to the amount of
total platelet proteins in order to avoid a loss of signalling
molecules from rafts during isolation as observed in other
cells [18,19]. Based on the classic characteristics of lipid
rafts, the isolation procedures where low concentrations of
Triton X-100 (0.1% or less) are used appear to be valid
under conditions where the amount of human platelets per
sample is well controlled [16,17,19]. Another nonionic
detergent, Brij 58, has also been recently employed for
platelet rafts isolation and seems to preserve these micro-
domains, even when used at high concentrations [19].
Despite the fact that it is always difficult to separate two
domains of a membrane with a high yield and without
impurities by biochemical methods, the results obtained by
different groups using various concentrations of detergent
allow one to draw a general characterization of human
platelet lipid rafts. When isolated by the classical method
(1% Triton X-100 and sucrose gradient) platelet rafts appear
as round vesicles of heterogeneous size ranging from 20 to
500 nm [14,16]. They have less than 1% of total platelet
proteins, lack caveolin, which is not expressed in these cells,
and are highly enriched in the membrane glycoprotein
CD36 (Table 1). The impact of CD36 on raft structure is
yet unknown and it would therefore be interesting to
investigate its role in CD36-deficient platelets (Nak(a)-
negative platelet phenotype). Although weakly detected in
isolated rafts, other significant plasma membrane glycopro-
teins such as GPIb, GPIIIa and CD9 are predominantly
found in the Triton X-100 soluble fraction of resting
platelets [14]. In contrast, the h1 integrin subunit is
restricted to the detergent-soluble fraction and may be
considered as a non-raft transmembrane marker protein
[19]. The transmembrane adapter LAT [17,20], as well as
the tyrosine kinases of the Src family, notably Lyn [14,15],
are present to a high level in rafts isolated from resting
platelets. As observed in other hematopoı¨etic cells, platelet
rafts are enriched in the GM1 ganglioside, known to
preferentially partition into liquid ordered domains [17]
(Fig. 1). The cholesterol/phospholipid molar ratio is 1.2 in
rafts versus 0.5 in whole platelets and indicates a clear
cholesterol enrichment [16] (Fig. 1). Sphingomyelin is the
major phospholipid of isolated rafts, representing about 57
mol% of the total raft phospholipids and about 35% of total
platelet sphingomyelin. The fatty acid composition of
sphingomyelin in rafts is not significantly different from
that in whole platelets and is mainly composed of saturated
fatty acids (behenic>lignoceric>palmitic) and one mono-
unsaturated fatty acid (nervonic acid) [16]. Small amounts
( < 5%) of phosphatidylcholine, phosphatidylserine and
phosphatidylethanolamine are detected in isolated rafts but
these phospholipids display a marked enrichment in satu-
rated fatty acids, particularly in palmitic, stearic and arachi-
dic acids with a concomitant decrease of unsaturated fatty
acids [16]. It is noteworthy that when low concentrations of
Triton X-100 are used to isolate rafts, the amount of
phosphatidylcholine increases but the levels of the other
lipids do not change significantly [Bodin et al., personal
observation].
Besides RBL-2H3 mast cells [21], human platelets are
another example of enrichment in molecular species con-
taining saturated fatty acyl chains in rafts. This enrichment is
consistent with a model in which the lipid bilayer in rafts is
asymmetric with sphingomyelin and glycosphingolipids
enriched in the outer leaflet and saturated glycerophospho-
lipids enriched in the inner leaflet [7,9,21]. In the presence of
cholesterol, saturated glycerophospholipids would facilitate
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the formation of a liquid ordered phase in the inner leaflet of
the plasma membrane. For example, in vitro experiments
have shown that a mixture of monounsaturated phosphati-
dylcholine and cholesterol is partially Triton X-100 insoluble
at low temperature [22]. This is an important issue because,
due to the potential lipid asymmetry of rafts, one leaflet
might be more resistant to detergent than the other.
Recently, using a particular fluorescence microscopy
technique, Fourier transform infrared spectroscopy (FTIR),
Gousset et al. [23] have obtained evidence that rafts are
present in the plasma membrane of human platelets at
physiological temperatures and can aggregate upon stimu-
lation. Although the small size of rafts and platelets is a
limitation for the clear visualization of these microdomains
Fig. 1. Representation of three of the quantitatively major and representative lipids found in rafts isolated from human platelets.
Table 1
Signalling proteins and lipid second messengers found so far in rafts isolated from resting or activated human platelets
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by microscopy in general, it is now necessary to develop
these approaches to confirm the biochemical data.
Altogether, these results indicate that, like other hema-
topoı¨etic cells, platelets contain lipid rafts that are likely to
be highly dynamic microdomains of the plasma membrane,
if we refer to their fast lateral movements and their capacity
to aggregate.
3. Phase transition and raft aggregation during platelet
activation
A number of studies have shown that cold temperatures
(below 18 jC) can induce platelet activation [24–26] and,
for this reason, platelet concentrates must be stored at 22 jC
in blood banks. Tablin et al. [27] have investigated whether
low temperatures would initiate signalling events through
modification of the fluidity of the platelet plasma mem-
brane. These authors have demonstrated that upon cooling
through the phospholipid membrane phase transition (15
jC), platelets change their shape with emission of pseudo-
podial projections [27]. Using diI-C18 (1,1V-dioctadecyl-
3,3,3V,3V-tetramethyl-indocarbocyanine perchlorate), a fluo-
rescent dye expected to preferentially partition into ordered
lipid domains, Gousset et al. [23] have shown by FTIR that
lipid raft-like domains aggregate during the initial steps of
platelet activation upon chilling (Fig. 2). Interestingly, this
lipid phase separation upon cooling appeared to be a
reversible process [23]. Using the same technique, it was
shown that upon stimulation by physiological agonists, such
as thrombin or collagen, lipid rafts also coalesce at 37 jC
[23]. Methyl-h-cyclodextrin (MhCD), which efficiently
removes cholesterol from the plasma membrane and thus
disrupts lipid raft organization, inhibited these events. These
observations support previous results suggesting a redistrib-
ution of cholesterol within the plasma membrane upon
collagen stimulation [28]. Thus, this dynamic process might
represent a critical mechanism for the early steps of platelet
activation under physiological conditions. These results are
in agreement with observations showing that, in several
hematopoietic cells, clustering of small lipid rafts into larger
aggregates participates in the formation of signalling plat-
forms [7,8].
4. Implication of lipid rafts in GpVI-mediated platelet
activation
Platelet adhesion to the exposed subendothelium at sites
of tissue damage is one of the first critical steps in the
complex processes required for the prevention of bleeding
[29]. At high shear forces, in damaged arteries or arterioles,
adhesion of platelets to von Willebrand’s factor (vWf)
through the surface glycoprotein GpIb-IX-V is an important
initial mechanism of the repair process. At lower flow rates,
collagen and fibrinogen can support adhesion of platelets.
The integrin a2h1 is a collagen receptor [30] involved in
platelet adhesion to most forms of collagen under flow
conditions. Besides this initial stage of adhesion via a2h1,
another collagen receptor, GpVI, restricted to megakaryo-
cytes and platelets [31], is strongly involved in the platelet
activation process [5]. GpVI initiates a signalling cascade
comparable to the one activated by immune receptors [3].
This activating pathway will lead to the secretion of mol-
ecules such as ADP, which will further stimulate platelets,
and to the activation of the aIIbh3 integrin, allowing
Fig. 2. Chilling- as well as thrombin- or collagen-induced aggregation of platelet lipid rafts. Several studies [14–17,23] strongly suggest that, in resting
platelets, lipid microdomains in liquid ordered phase, displaying the characteristics of rafts, have a homogeneous distribution in the platelet plasma membrane.
These lipid microdomains appear to coalesce in the early stages of platelet activation induced by chilling or by physiological agonists.
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fibrinogen binding and in turn interaction between platelets
and finally aggregation [3,5]. Genetic and biochemical
studies have demonstrated that, like immune receptors,
functional GpVI requires the formation of a multimeric
complex [3,5,32]. The Fcg-chain, an immuno-receptor tyro-
sine-based activation motif (ITAM)-containing transmem-
brane protein, plays a critical role in GpVI-mediated platelet
activation [5,33,34]. Fcg-chain is phosphorylated by the Src
kinases, Lyn and Fyn, allowing the recruitment and the
activation of the tyrosine kinase Syk. Syk will, in turn,
phosphorylate key adapter molecules like LAT and SLP-76
and regulate critical signalling proteins such as PLCg2
[5,35–37].
The role of lipid rafts in GpVI-mediated platelet activa-
tion was first indirectly suggested by Boesze-Battaglia et al.
[28] who observed a redistribution of cholesterol within the
platelet plasma membrane upon collagen stimulation. Wat-
son et al. [5] also obtained biochemical evidence suggesting
a role of lipid rafts in GpVI-dependent platelet activation.
These observations were recently confirmed by Wonerow et
al. [19] and Locke et al. [17] using both human platelets and
the basophilic RBL-2H3 cell line expressing GpVI. Locke
et al. [17] demonstrated that GpVI is not present in rafts
isolated from resting cells but is massively recruited to these
microdomains following receptor stimulation. The optimal
recovery of clustered GpVI in rafts is observed with an
isolation procedure using very low concentrations of Triton
X-100. Using Brij 58 as a detergent for raft isolation,
Wonerow et al. [19] found a considerable amount of GpVI
in rafts from resting platelets and no major change in its
distribution upon stimulation. This discrepancy suggests a
rather weak association of GpVI with lipid rafts that may be
well preserved by Brij 58 and only partially by Triton X-100
when rafts are isolated from resting platelets. Locke et al.
[17] suggest that the Fcg-chain is required for the stable
association of GpVI with lipid rafts upon activation [17], but
the molecular basis of this mechanism is still unknown.
Phosphorylated Fcg-chain is exclusively found in lipid rafts,
but this phosphorylation is not required for the association
of GpVI with the microdomains [17]. The transmembrane
domain of the Fcg-chain may be critical for the specific
targeting of oligomerized GpVI receptors. An arginine
residue in the transmembrane domain of GpVI can form a
salt bridge with an aspartic residue in the transmembrane
domain of Fcg-chain to stabilize the complex [34]. How-
ever, it is still unclear whether the Fcg-chain directly drives
the force to target GpVI in the microdomains or whether it
uses intermediate molecules.
These studies suggest that phosphorylated Fcg-chain
specifically organizes signalling events in lipid rafts where
other proteins such as the docking protein LAT will sub-
sequently coordinate downstream mechanisms. This is con-
sistent with the fact that cholesterol depletion using MhCD
strongly affects the tyrosine phosphorylation events induced
by GpVI triggering [5, Bodin et al., Thromb. Haemost. (in
press)]. The phosphorylation of the Fcg-chain by Lyn may
specifically occur in platelet rafts since active Lyn is
selectively enriched in these microdomains [15]. LAT is
known to concentrate in T lymphocyte rafts where it plays a
central role in the organization of functional signalling
complexes downstream of immune receptors [19,38,39].
Palmitoylation of cysteines 26 and 29 of LAT is responsible
for the targeting of this adapter molecule in T lymphocyte
lipid rafts [40]. Once phosphorylated (mainly by Syk in
platelets and Zap-70 in T lymphocytes), LAT can associate
with several proteins, including the p85a subunit of phos-
phoinositide 3-kinase (PI 3-kinase), Grb2, PLCg2, Gads and
SLP-76 [19]. In platelets, LAT has a major role in the
tyrosine phosphorylation and the activation of PLCg2
downstream of GpVI and is required for normal platelet
activation via collagen or collagen-related peptide [35].
However, despite a lack of platelet response to GpVI,
LAT-deficient mice have no bleeding phenotype. This is
in contrast with the dramatic bleeding problems observed in
SLP-76- [36] or Syk- [33] deficient mice. These two
proteins, which are not classical raft proteins, play a critical
role in platelet activation via GpVI [37,41,42]. Wonerow et
al. [19] found that a small fraction of tyrosine-phosphory-
lated Syk and SLP-76 is recruited to these domains upon
GpVI triggering. However, since the majority of these
phosphotyrosyl proteins are present outside the rafts, the
authors suggest either a transient association of these
molecules with the microdomains or a dissociation of the
complex upon cell lysis. A participation of Syk and SLP-76
in biochemical events occurring outside lipid rafts is also
likely.
Thus, strong arguments are in favour of a role of lipid
rafts in GpVI-mediated platelet activation but several points
need to be clarified to better understand the sequence of
molecular events taking place in these microdomains. An
interesting aspect would be to investigate whether the other
collagen receptor, a2h1, can function independently of lipid
rafts.
5. A role for lipid rafts in a critical step of
Fc;RIIa-mediated platelet activation
Fc;RIIa is the only class of immune Fc; receptor
expressed in platelets and is involved in several pathologies,
including heparin-associated thrombocytopenia (HIT) [43–
47]. HIT occurs in patients under heparin therapy who
develop IgG against heparin–platelet factor 4 complexes
at the platelet surface. Binding of Fc fragments of this IgG
on Fc;RIIa leads to the activation of a signalling pathway
that contributes to thrombosis and/or rapid destruction of
platelets. In this process, secreted ADP is a crucial co-factor
that positively modulates platelet activation induced by
Fc;RIIa stimulation [48,49].
Upon cross-linking of Fc;RIIa, either by successive
additions of the nonactivating specific anti-Fc;RIIa mono-
clonal antibody IV-3 and F(abV)2 fragments or by addition of
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HIT sera and heparin, this receptor becomes rapidly tyro-
sine-phosphorylated in its ITAM motif, probably via Lyn.
The phosphorylated ITAM is a docking site for SH2
domain-containing signalling proteins, including the kinase
Syk, involved in the tyrosine phosphorylation of LAT and
PLC;2 [50–52]. The phospholipase is responsible for the
production of the second messengers inositol (1,4,5)-tri-
sphosphate (IP3) and diacylglycerol (DAG), key signalling
events for Fc;RIIa-dependent platelet secretion and aggre-
gation [52].
Recently, our group has investigated the role of lipid rafts
in the spatio-temporal organization and the integration of
Fc;RIIa-dependent signalling events [Bodin et al., Thromb.
Haemost. (in press)]. Upon cross-linking, Fc;RIIa mas-
sively relocates in lipid rafts where the kinase Lyn and the
adapter LAT are among the major phosphotyrosyl proteins.
Moreover, upon stimulation of human platelets by HIT sera,
PtdIns(3,4,5)P3 is preferentially produced in lipid rafts. This
lipid, whose production is dependent on co-activation by
secreted ADP via its P2Y12 receptor, appears to be required
to specifically recruit PLC;2 and/or to stabilize its presence
in platelet rafts [52,53]. In human platelets activated through
Fc;RIIa, as well as GpVI, tyrosine phosphorylation of
PLC;2 is required but not sufficient to activate the enzyme
since the early synthesis of the PI 3-kinase product,
PtdIns(3,4,5)P3, is an obligatory step in this mechanism
[52,53]. PtdIns(3,4,5)P3 can directly interact with the PH
domain and/or the SH2 domain of PLC;2 and participates
in the adequate localization of this phospholipase [52] close
to its substrate, the PtdIns(4,5)P2 [54]. In human platelets,
the generation of phosphatidic acid (PtdOH) via phosphor-
ylation of DAG is a good indication of PLC activation
[55,56]. In agreement, an important proportion of PtdOH
was detected in rafts isolated from platelets activated via
Fc;RIIa. This production was blocked by PI 3-kinase
inhibitors or antagonists of the P2Y12 ADP receptor. In
Fig. 3. Involvement of lipid rafts in GpVI and FcgRIIa-mediated platelet activation. (A) Upon stimulation, a considerable amount of GpVI molecules is present
in lipid rafts [17,19] together with the ITAM-containing Fcg-chain which appears to be exclusively tyrosine-phosphorylated in these cholesterol-rich membrane
domains [17]. (B) Upon clustering, FcgRIIa associates with lipid rafts in its tyrosine-phosphorylated form. The other major tyrosine-phosphorylated proteins in
rafts are the tyrosine kinase Lyn and the adapter LAT. Converging signalling pathways from FcgRIIa and P2Y12 ADP receptor [53] are required for the
production of a high proportion of PtdIns(3,4,5)P3 in lipid rafts, which in turn, allows the recruitment and the activation of PLCg2. Thus, lipid rafts appear as
membranous sites where critical steps of the FcgRIIa-mediated signalling pathway are organized leading to efficient platelet activation.
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order to assess the role of rafts in Fc;RIIa-mediated platelet
activation, these microdomains were destabilized by choles-
terol depletion using MBCD. In this context, it is important
to note that the conditions to use MBCD have to be carefully
adjusted according to the cell type. For instance, 5 mM
MBCD can deplete more than 45% of total human platelet
cholesterol within 5 min. Under conditions where 40%
cholesterol is depleted, a slight secretion can be observed
and no perturbation of shape change, secretion and aggre-
gation is noted in response to thrombin at concentrations
above 0.5 IU/ml [Bodin et al., Thromb. Haemost. (in
press)]. This controlled cholesterol depletion induced a
significant disruption of platelet rafts and impaired the
association of Fc;RIIa with the remnants of lipid rafts
without affecting significantly the tyrosine phosphorylation
events induced by Fc;RIIa clustering. However, the pro-
duction of PtdIns (3,4,5)P3 and the activation of PLC;2
were strongly inhibited in whole platelets. This inhibition
was reversible as complete cholesterol repletion restored
PLC;2 activation. These results highlight the role of the
lipid second messenger, PtdIns(3,4,5)P3, in the recruitment
and/or the stabilization of PLC;2, a key protein of the
signal transduction cascade in lipid rafts (Fig. 3).
The fact that the tyrosine phosphorylations initiated by
Fc;RIIa cross-linking are only weakly sensitive to choles-
terol depletion and raft disruption, while collagen-mediated
tyrosine phosphorylations are highly sensitive, suggests a
differential role of rafts in the organization of these two
platelet activating pathways. Partial disruption of rafts may
be sufficient to inhibit the phosphorylation processes in the
case of receptors that function as coordinated complexes,
such as TCR or collagen GpVI receptor, which require the
ITAM containing Fc; chain to signal. In the case of
Fc;RIIa, which possesses its own ITAM, the early phos-
phorylation mechanisms are less sensitive to raft disruption
and these laterally segregated microdomains are rather
essential to organize key downstream events such as PI 3-
kinase and PLC;2 activation.
6. G-protein coupled receptor signalling in lipid rafts
The role of lipid rafts in G-protein coupled receptor-
mediated signalling is still poorly characterized in general.
In human platelets, thrombin is one of the best known
physiological agonist and acts through the seven transmem-
brane domains containing receptors PAR1 and PAR4 [57].
We have observed that thrombin stimulation leads to mor-
phological changes of isolated platelet rafts. This is corre-
lated with a rapid association of the A subunit of the
heterotrimeric G proteins Gq [16] and Gi [Bodin et al.,
our unpublished data] with the microdomains and the
production of lipid second messengers in rafts [16]. Choles-
terol depletion with MBCD reversibly impairs these bio-
chemical events as well as platelet secretion and aggregation
induced by low doses of thrombin ( < 0.3 IU/ml). These
observations are in agreement with the results of Gousset et
al. [23] showing by FTIR that cholesterol- and sphingolipid-
rich domains aggregate during the initial steps of platelet
activation induced by thrombin. However, at high concen-
trations of thrombin, we observed that 40% to 50% choles-
terol depletion does not significantly affect platelet
aggregation. Taken together, these results suggest that lipid
rafts are mainly involved in the mechanism of activation
induced by the high affinity thrombin receptor (PAR1).
7. Phosphoinositide (PI) signalling pathway in platelet
rafts
PIs are quantitatively minor phospholipids (about 10% of
total phospholipids) but they have a highly active metabo-
lism and play a crucial role in many mechanisms of cell
regulation [54]. Several PIs are specifically involved in the
control of the spatial and temporal organization of key
signalling pathways leading to cell proliferation or survival,
rearrangement of actin cytoskeleton or intracellular vesicle
trafficking. Various cellular agonists control the activity and/
or the recruitment of kinases, phosphatases or phospholi-
pases involved in the tight control of the intracellular level
of polyphosphoinositides. This metabolism is highly active
in platelets and plays a central role in these cells.
The remarkable feature of PIs, which can be rapidly
synthesized and degraded in discrete membrane domains or
subcellular structures, places them as accurate regulators
and integrators of dynamic mechanisms of cell regulation
[54]. They can directly and specifically interact with func-
tional protein modules such as pleckstrin homology (PH),
FYVE or Phox (PX) domains, thus allowing membrane
targeting of several signalling proteins. Evidence suggests
that distinct metabolic pools of PIs exist in various cell
types, but we have only a rough idea of the spatial
organization of intracellular PI metabolism dynamics.
In nucleated cells [58–60], as well as in platelets [16],
cholesterol- and sphingolipid-rich membrane domains
appear as site where the PI metabolism is highly active,
suggesting a production of DAG and InsP3 in these micro-
domains. One might think that the unsaturated arachidonic
acid of PIs would not fit into the raft model as it contains
saturated fatty acid phospholipids in the inner leaflet. How-
ever, our data support the idea that PIs, which are quanti-
tatively minor lipids in these microdomains, are not
backbone components of rafts but rather signalling mole-
cules able to rapidly interact with specific targets. In this
context, an important issue is to understand how these PIs
are kept concentrated in lipid rafts. The implication of
specific PI-binding proteins such GAP43, MARCKS or
CAP23, also called Pipmodulines, has recently been sug-
gested [61]. These proteins interact with PtdIns(4,5)P2 and
are proposed to retain or mask this PI in raft-like membrane
microdomains, thus regulating its accessibility to other
regulatory proteins. For example, proteins involved in the
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dynamic organization of the actin cytoskeleton, such as
proteins belonging to the WASP–Arp2/3 complex actin
nucleation machinery, could also be recruited to lipid rafts
through their binding to this PI [54,62]. In this respect, it is
interesting to note that PtdIns(4,5)P2 has been shown to
induce actin-based movements of raft-enriched vesicles
through the WASP–Arp2/3 pathway [63].
In addition to PtdIns(4,5)P2, our study reveals that
PtdIns(3,4,5)P3 is largely produced and/or concentrated in
these microdomains upon platelet stimulation and plays an
important role in recruiting or stabilizing PLC;2 [52,53]
and other enzymes containing a PH domain such as the
tyrosine kinases BTK and Tek [54]. The presence of
PtdIns(3,4,5)P3 in lipid rafts might be a general mechanism
in activated hematopoı¨etic cells and could explain, for
example, some of the roles of this second messenger in
lymphocytes. One of the limiting steps in the production of
PtdIns(3,4,5)P3 in rafts may be the access of PtdIns(4,5)P2
to activated PI 3-kinase. As seen above, this access could be
partly modulated by Pipmodulin proteins.
8. Variation of plasma membrane cholesterol
concentration in platelet physiopathology
The question of the role of cholesterol in platelet activa-
tion was addressed in the 1970s, at a time when the notion
of lipid rafts had not been yet developed. Several studies
showed that cholesterol content and platelet function were
altered in some dyslipoproteinemias [64–67]. These
changes in cholesterol concentration are likely explained
by molecular mechanisms established in the megakaryocyte
[68]. Indeed, de novo cholesterol synthesis does not occur in
platelets and the cholesterol exchange process, which can
take place in plasma, was shown not to be responsible for a
net uptake of cholesterol into platelets [68]. A good corre-
lation was observed between increased cholesterol content
or cholesterol/phospholipid ratio and increased platelet
responsiveness in vitro [68–70]. For example, platelets
from Type IIa hypercholesterolemia patients have a higher
membrane cholesterol content [66] and display increased
reactivity to collagen and ADP [65,68]. However, the
cholesterol content may not be the only abnormality in
platelets from patients with genetic dyslipoproteinemias.
Therefore, studies in which the cholesterol content of
normal platelets was altered by cholesterol–phospholipid
dispersions in vitro were undertaken. Incubation of normal
platelets with cholesterol-rich liposomes resulted in a similar
hyperreactivity [68–70] and a reduced inhibitory effect of
prostaglandin E1 [68]. Thus, manipulation of the cholesterol
content of platelets in vitro has somehow mimicked the
hyperreactivity of platelets from individuals with Type IIa
hypercholesterolemia. Conversely, other studies have shown
that platelets with a cholesterol/phospholipid ratio lower
than 0.51 have a decreased reactivity to epinephrine and
ADP [71,72]. These results indicate that this particular lipid
plays a critical role in early platelet activation. Together with
our recent observations, they suggest that hypercholester-
olemia may be a supplementary factor of risk to develop
thrombosis in patients suffering of HIT.
The fact that changes in cholesterol affect several platelet
responses suggests that this lipid is part of a general process
contributing to an efficient platelet activation. One can
consider that these results are consistent with a role of
cholesterol in the organization and stabilization of lipid rafts
and thus in the control of raft-mediated events. However,
changes in cholesterol concentration will probably primarily
modify raft organization but also, to some extent, the
membrane fluidity. Therefore, these observations do not
permit unambiguous conclusions at this stage but suggest
that a modification in platelet cholesterol/phospholipid ratio
may influence raft organization and therefore platelet func-
tions. This modification could contribute, in some cases, to
an increased risk of thrombosis in patients with hyper-
cholesterolemia.
9. Conclusions
Altogether, the results commented above strongly sug-
gest that lipid rafts are highly dynamic platelet membrane
structures involved in critical signalling mechanisms. Like
in T cell activation [73], the membrane compartmentaliza-
tion appears to be required for efficient platelet activation
via receptors or co-receptors containing an ITAM motif.
However, due to the limits of the techniques used until now,
many aspects of the role of lipid rafts in platelets remain
uncertain. The use of new techniques such as real-time
imaging should help to appreciate the dynamic of platelet
rafts and their contribution to a specific mechanism. The
development of raft isolation procedures at physiological
temperature with detergents such as Brij 98 [74] could also
help to preserve their native state and to identify the proteins
found in these microdomains.
In this context, Shrimpton et al. (personal communica-
tion, ISTH XVIIIth Congress, Paris 2001) suggested that
members of the GpIb-IX-V complex (palmitoylated GpIX
and GpIbB) localize in platelet rafts. Moreover, GpIb has
been shown to associate with Fc;RIIa [75] possibly in the
microdomains. This important point requires an extensive
investigation which may provide a better understanding of
the role of rafts in platelet biology.
Although the activation of Syk and the tyrosine phos-
phorylation of PLC;2 by AIIB3 do not depend on rafts [19],
it will be important to investigate the role of these micro-
domains in the late platelet responses such as clot retraction.
The interaction of actin cytoskeletal elements with lipid rafts
has been described in lymphocytes [76] and could represent
an important aspect in platelet activation processes. Indeed,
the actin cytoskeleton is strongly reorganized during platelet
activation and may participate to maintain the lateral
assembly of these microdomains in the membrane, possibly
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via PtdIns(4,5)P2 [54,61–63]. The contractile forces
required for clot retraction could take place through cytos-
keleton-associated lipid rafts. In this respect, it would be
interesting to investigate whether the major platelet integrins
can associate with lipid rafts during the irreversible phase of
platelet aggregation.
Finally, we have obtained some evidence that different
populations of rafts may coexist or be generated during
platelet activation. The identification of the specific func-
tions of these different microdomains should help to better
understand how the dynamic organization of the plasma
membrane participates in the control of platelet biology in
normal and pathological situations.
Note added in proof
Two recent studies highlight the role of rafts in platelet
activation: Shrimpton et al. J. Exp. Med. 2002, 196, 1057–
66 and J. Biol. Chem. 2003, in press.
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